CompletedPhase 1NCT01932437
Intramuscular Dose-Escalation Study With ETI-204 in Adult Volunteers
Studying Inhalational anthrax
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Elusys Therapeutics
- Principal Investigator
- Alex King, MD, mdCovance Clinical Research Unit
- Intervention
- ETI-204(biological)
- Enrollment
- 36 target
- Eligibility
- 18 years · All sexes
- Timeline
- 2013 – 2014
Study locations (1)
- Covance Clinical Research Unit Inc., Dallas, Texas, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01932437 on ClinicalTrials.gov